A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: Results from the ADAMO trial

Bente L. Langdahl, Christence Stubbe Teglbjærg, Pei Ran Ho, Roland Chapurlat, Edward Czerwinski, David L. Kendler, Jean Yves Reginster, Alan Kivitz, E. Michael Lewiecki, Paul D. Miller, Michael A. Bolognese, Michael R. McClung, Henry G. Bone, Östen Ljunggren, Bo Abrahamsen, Ugis Gruntmanis, Yu Ching Yang, Rachel B. Wagman, Faisal Mirza, Suresh SiddhantiEric Orwoll

Research output: Contribution to journal › Article › peer-review

91 Scopus citations

Fingerprint

Dive into the research topics of 'A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: Results from the ADAMO trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds